Skip to main navigation

+44 (0)20 8154 4600
info@achillestx.com

Home
About Us
Science
Publications
Pipeline
- PIPELINE
- EXPANDED ACCESS
Investors & Media
CAREERS
Contact

Press Releases

Home
About Us
Science
Publications
Pipeline
- PIPELINE
- EXPANDED ACCESS
Investors & Media
CAREERS
Contact

Year

All News
2024
2023
2022
2021
2020
2019
2018
2017
2016

Oct 1 2021

Achilles Therapeutics to Present at Upcoming Scientific Congresses

Read More +

Sep 2 2021

Achilles Therapeutics to Present at Upcoming Investor Conferences

Read More +

Aug 25 2021

Achilles Therapeutics Announces Grant of US and European Patents

Read More +

Aug 10 2021

Achilles Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlights

Read More +

Jul 1 2021

Achilles Therapeutics Enrolls First US Patient in Ongoing Phase I/IIa Study in Advanced Non-small Cell Lung Cancer

Read More +

Jun 4 2021

Achilles Therapeutics Details Phase I/IIa Clinical Trial Design of CHIRON in Patients with Advanced Non-Small Cell Lung Cancer at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Read More +

May 11 2021

Achilles Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Highlights

Read More +

May 6 2021

Achilles Therapeutics Receives Horizon 2020 Grant as Part of Neoantigen Consortium

Read More +

May 5 2021

Achilles Therapeutics to present at the BofA Securities 2021 Virtual Healthcare Conference

Read More +

May 3 2021

Achilles Therapeutics Appoints Julie O’Neill to Board of Directors and Markwin Velders, Ph.D. joins Scientific Advisory Board

Read More +

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
Next page
Last page

Print Page

RSS Feeds

Email Alerts

Contact IR

Home
About Us
Science
Publications
Pipeline
Investors & Media
Work with us
Contact

UK Headquarters:
Achilles Therapeutics plc
245 Hammersmith Road
London
W6 8PW, UK

US Headquarters:
Achilles Therapeutics US, Inc.
401 N. Broad Street
Suite M121
Philadelphia, PA 19108

+44 (0)20 8154 4600
info@achillestx.com

© Copyright - Achilles Therapeutics plc.

Achilles Therapeutics plc (13027460) is registered in England and Wales. The registered office is at 245 Hammersmith Road, London, W6 8PW.

Privacy & Cookie Policy

Terms & Conditions